Bisphosphonates may be commonly prescribed to help slow bone loss, but could these drugs also be causing issues for your patients in terms of their oral health? A recent investigation into the subject ...

September 21, 2011 (San Diego, California) — Bisphosphonate therapy for osteoporosis is much more likely to be effective among patients whose blood serum levels of vitamin D are elevated, according to ...

Nonsteroidal anti-inflammatory drugs (NSAIDs) seemed to neutralize the protective benefit of a certain bisphosphonate, according to a post-hoc analysis of a randomized controlled trial. Among over ...

The use of bisphosphonates, particularly risedronate, in patients with osteoporosis is linked to a higher risk for acute angle closure but not open-angle glaucoma. Researchers conducted a ...

Oral bisphosphonates are effective for the prevention and treatment of osteoporosis. Powerful second- and third-generation parenteral bisphosphonates, including pamidronate and zoledronate, are also ...

Since 2007, there have been several reports suggesting a potential association between the use of bisphosphonates and the occurrence of subtrochanteric or so-called atypical femoral fracture. 1–4 ...

A variety of criteria have been used in the literature to diagnose ONJ. In 2006, however, a multidisciplinary task force appointed by the American Society for Bone and Mineral Research proposed a ...

The presence of bone metastases in patients with metastatic renal cell carcinoma treated with oral tyrosine kinase inhibitors (TKIs) is associated with poorer outcome as compared with patients without ...

Please provide your email address to receive an email when new articles are posted on . Among South-East Asian adults, bisphosphonate use in is not associated with differences in clinical outcomes or ...

In advance of the anticipated effective date of the Horseracing Integrity and Safety Authority's (HISA) Anti-Doping and Medication Control (ADMC) Program on March 27, 2023, the Horseracing Integrity & ...